Tag: fda-approved-treatment

Picture Gallery Venture Capital

Ritter Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

August 7, 2017
Presse

LOS ANGELES, CA -- (Marketwired) -- 08/07/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or…

Continue Reading
Picture Gallery Venture Capital

Ritter Pharmaceuticals, Inc. Announces End of Phase 2 Meeting with the FDA and Initiates Phase 3 Program Development Activities

April 12, 2017
Presse

LOS ANGELES, CA -- (Marketwired) -- 04/12/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (the "Company") today,…

Continue Reading